Search

Your search keyword '"Seelaar, Harro"' showing total 560 results

Search Constraints

Start Over You searched for: Author "Seelaar, Harro" Remove constraint Author: "Seelaar, Harro"
560 results on '"Seelaar, Harro"'

Search Results

1. A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

2. Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

3. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia.

4. Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia

6. Temporal order of clinical and biomarker changes in familial frontotemporal dementia

7. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

8. Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia − A GENFI study

9. Altered plasma protein profiles in genetic FTD – a GENFI study

13. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

14. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

15. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

16. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

18. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

19. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

20. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders

21. The Benson Complex Figure Test detects deficits in visuoconstruction and visual memory in symptomatic familial frontotemporal dementia: A GENFI study

23. Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

25. Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia.

26. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

27. Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia

28. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

29. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

30. Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

31. Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia

32. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog

33. Letter to the editor on a paper by Kaivola et al. (2020): carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is not associated with amyotrophic lateral sclerosis or frontotemporal dementia

36. Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study.

38. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

39. Cerebrovascular reactivity impairment in genetic frontotemporal dementia

40. Distinctive cell‐free DNA methylation characterizes presymptomatic genetic frontotemporal dementia

41. Generalizability of trial criteria on amyloid-lowering therapy against Alzheimer’s disease to individuals with MCI or early AD in the general population

42. NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study

43. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results.

44. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia.

45. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

46. Examining longitudinal changes of disease severity scores in familial forms of frontotemporal dementia within the GENFI cohort

48. Targeted proteomic search reveals new actors in the synaptic and lysosomal dysfunction in genetic FTD, a GENFI study.

49. TREM2 Burden associates solely with Alzheimer’s Disease, and decreases the Chance to become a Centenarian

50. Developing a mass spectrometric assay to measure granulin peptides in CSF for progranulin‐associated frontotemporal dementia

Catalog

Books, media, physical & digital resources